AT & S Austria Technologie & Systemtechnik (ATS) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
16 Nov, 2025Executive summary
Revenue and EBITDA increased year-over-year in Q1, with a stable EBITDA margin and a strong focus on cash flow and profitability, supported by cost-saving initiatives and positive market developments in PCBs and IC substrates.
High-volume production started at new mass manufacturing sites in Kulim, Malaysia, and Leoben-Hinterberg III, Austria, ramping up for high-performance IC substrates, especially for AI applications.
Cost-saving and efficiency programs delivered €45 million in Q1 and are targeting €130 million for FY25/26, on top of €120 million already realized.
Artificial intelligence-related investments are key growth drivers, with stable and improving markets for both PCBs and IC substrates.
Loss for the period widened to €56 million, mainly due to FX impacts and ramp-up costs.
Financial highlights
Q1 revenue increased 14.2% year-over-year to €398.9 million, with EBITDA up 9.4% to €70.6 million and margin stable at 18%.
Net loss for the period was €56 million, with EPS at €-1.55 versus €-0.99 prior year.
Operating free cash flow improved to €130 million, supported by working capital improvements and a 40% reduction in net CapEx.
Cash and cash equivalents increased to €924 million, with financing costs at 3.9%.
Net debt/EBITDA ratio improved to 2.3x, and equity ratio declined to 19.4% due to FX effects.
Outlook and guidance
H1 2025/26 revenue expected at approximately €820 million, with EBITDA margin around 20% and net CapEx at €110 million.
Full-year guidance is pending due to market and FX volatility, especially regarding US tariffs.
Midterm guidance for FY 2026/27: revenue €2.1–2.4 billion, EBITDA margin 24–28%.
Equity ratio may temporarily fall below 20%.
Latest events from AT & S Austria Technologie & Systemtechnik
- Revenue up 10% to €1.314B, EBITDA margin 23%, strong outlook despite FX and supply risks.ATS
Q3 20263 Feb 2026 - Adjusted EBITDA margin rose to 27.6% despite revenue decline and net loss.ATS
Q1 20252 Feb 2026 - Stable revenue, margin gains, and Ansan sale boost liquidity amid ongoing market pressure.ATS
Q3 20259 Jan 2026 - Revenue, EBITDA, and cash flow improved, but FX and supply chain risks persist.ATS
Q2 202616 Dec 2025 - Revenue up 3%, EBITDA margin at 26%, with major investments and cost savings; outlook cautious.ATS
Q4 202521 Nov 2025 - Revenue and earnings fell amid price pressure, but mid-term growth targets are reaffirmed.ATS
Q2 202513 Jun 2025